Hepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC)
globally. Vaccination is the most effective method for prevention of hepatitis B and its …

Vaccinating patients receiving dialysis may prevent morbidity and mortality in this vulnerable
population. The National Forum of End-Stage Renal Disease Networks (the Forum) …

Importance Nonresponse to hepatitis B vaccine is common among people with HIV,
resulting in vulnerability to infection with hepatitis B virus (HBV). Objective To compare the …

Cancer immunotherapy, or the utilization of components of the immune system to target and
eliminate cancer, has become a highly active area of research in the past several decades …

Hepatitis B is one of the killer communicable diseases, with a global estimation of 1.1 million
deaths resulting from liver diseases annually. The search for HBV therapeutics has resulted …

The hepatitis B virus (HBV) is highly infectious, with over 292 million chronically infected
people worldwide and up to 2.4 million in the United States. Following infection, clinically …

Patients with chronic kidney disease (CKD) are susceptible to infectious organisms in part
due to the many facets of uremia-associated immune deficiency. Vaccination plays a crucial …

Purpose: This guideline on prevention and management of hepatitis B virus (HBV) infection
in adults with HIV has been developed by the New York State Department of Health AIDS …

The number of new infections of hepatitis B is rising and a large number of cases are
undiagnosed. These factors are contributing to hepatitis B-related liver complications …

Purpose: This guideline on prevention and management of hepatitis B virus (HBV) infection
in adults with HIV has been developed by the New York State Department of Health AIDS …